Carriers at higher risk of developing neurodegenerative disease
A team of Canadian scientists, including researchers at the Montreal Neurological Institute and Hospital (The Neuro), has discovered the first French-Canadian founder mutation gene linked to synucleinopathies, a group of neurodegenerative diseases that includes Parkinson鈥檚 disease (PD), dementia with Lewy-Bodies (DLB) and multiple system atrophy (MSA).
The mutation, known as p.Trp378Gly, is in the GBA gene, one of the most prominent genes involved in PD. The most common GBA mutations create a small risk of developing synucleinopathies, but in combination with other mutations, the risk can increase dramatically.
The study, funded in party by Healthy Brains for Healthy Lives (HBHL), found that one per cent of French Canadians with synucleinopathies have the GBA mutation. This mutation is specific to French Canadians and was probably inherited from a single common ancestor.
People who inherit this gene mutation from one parent become carriers of the mutation and are at risk of developing synucleinopathies. Those who inherit this gene mutation in addition to another mutation in GBA from both parents will develop Gaucher鈥檚 disease (GD). GD symptoms include enlargement of the spleen and liver, low red blood cell level, lung disease, arthritis, bone pain and fractures, but symptoms vary among patients.
鈥淲e don鈥檛 know how frequent this mutation is in the general French-Canadian population, but it doesn鈥檛 appear to be very common. We鈥檙e going to test additional subjects so we can determine its exact frequency,鈥� says Dr. Ziv Gan-Or, a genetics researcher at The Neuro and the study鈥檚 lead author. 鈥淭his mutation causes Gaucher鈥檚 disease, so it has clinical importance for couples who want to have children. They can request genetic screening for this specific gene mutation.鈥�
